Adaptyv Bio
Lausanne, Switzerland
◆ Total Raised
$40M
◆ Stage
series-a
◆ Location
Lausanne, Switzerland
◆ Founded
2020
◆ Team size
11-50
◆ Links
◆ About Adaptyv Bio
Adaptyv builds an automated AI-native lab for protein design and testing using cell-free synthesis and robotics, enabling AI agents to autonomously design, test, and learn from proteins at scale.
◆ What sets it apart
Adaptyv uniquely combines cell-free protein synthesis, robotics, and automated experimentation so AI agents can autonomously design, test, and learn from proteins in a closed loop.
◆ Sectors
◆ Business
Modelhardware
CustomerAI protein design teams, biotech startups, pharma companies, and frontier AI labs working on protein engineering
◆ Notable
- Launched a next-gen protein foundry and opened early access for protein designers
- Reached over 30 companies using the platform to validate protein designs
- Raised an $8M seed round
- Raised a $40M Series A
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Adaptyv Bio do?
Adaptyv builds an automated AI-native lab for protein design and testing using cell-free synthesis and robotics, enabling AI agents to autonomously design, test, and learn from proteins at scale.
Where is Adaptyv Bio based?
Adaptyv Bio is based in Lausanne, Switzerland, founded in 2020.
How much has Adaptyv Bio raised?
Adaptyv Bio has raised $40M in tracked funding and is currently at the series-a stage.
Who has invested in Adaptyv Bio?
Investors in Adaptyv Bio include Ace Ventures, ACE Ventures, Acequia Capital, byFounders, ByFounders, Founderful, Highland Europe and LongGame.